299 related articles for article (PubMed ID: 8683364)
41. Delayed facial palsy following uneventful middle ear surgery: a herpes simplex virus type 1 reactivation?
Bonkowsky V; Kochanowski B; Strutz J; Pere P; Hosemann W; Arnold W
Ann Otol Rhinol Laryngol; 1998 Nov; 107(11 Pt 1):901-5. PubMed ID: 9823837
[TBL] [Abstract][Full Text] [Related]
42. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.
Li L; Li Z; Wang E; Yang R; Xiao Y; Han H; Lang F; Li X; Xia Y; Gao F; Li Q; Fraser NW; Zhou J
J Virol; 2016 Jan; 90(2):790-804. PubMed ID: 26512084
[TBL] [Abstract][Full Text] [Related]
43. [An experimental study of herpes simplex virus infection in the facial nerve].
Fujiwara Y
Nihon Jibiinkoka Gakkai Kaiho; 1989 Jul; 92(7):1026-35. PubMed ID: 2553903
[TBL] [Abstract][Full Text] [Related]
44. Rapid strip assay for detection of anti-herpes simplex virus antibodies: application to prediction of varicella-zoster virus reactivation in patients with acute peripheral facial palsy.
Ohtani F; Furuta Y; Horal P; Bergström T
J Med Virol; 2000 Sep; 62(1):37-41. PubMed ID: 10935986
[TBL] [Abstract][Full Text] [Related]
45. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
[TBL] [Abstract][Full Text] [Related]
47. Neutralization antibody to herpes simplex virus type 1 in Bell's palsy.
Nakamura K; Yanagihara N
Ann Otol Rhinol Laryngol Suppl; 1988; 137():18-21. PubMed ID: 2849360
[TBL] [Abstract][Full Text] [Related]
48. Involvement of MAPK ERK activation in upregulation of water channel protein aquaporin 1 in a mouse model of Bell's palsy.
Fang F; Liu CY; Zhang J; Zhu L; Qian YX; Yi J; Xiang ZH; Wang H; Jiang H
J Mol Neurosci; 2015 May; 56(1):164-76. PubMed ID: 25527444
[TBL] [Abstract][Full Text] [Related]
49. Identification of the HSV-1 genome by "Dot Blot hybridization" in the geniculate ganglion of rabbits.
Llorente JL; Ona M; Suarez C; Melon S; Hidalgo F; Carreno M; Fernandez JA
Rev Laryngol Otol Rhinol (Bord); 1997; 118(3):163-5. PubMed ID: 9637103
[TBL] [Abstract][Full Text] [Related]
50. Acute facial paralysis: a virological study.
Mulkens PS; Bleeker JD; Schröder FP
Clin Otolaryngol Allied Sci; 1980 Oct; 5(5):303-10. PubMed ID: 6254700
[TBL] [Abstract][Full Text] [Related]
51. Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children.
Furuta Y; Ohtani F; Aizawa H; Fukuda S; Kawabata H; Bergström T
Pediatr Infect Dis J; 2005 Feb; 24(2):97-101. PubMed ID: 15702035
[TBL] [Abstract][Full Text] [Related]
52. [Acute viral infections in association with idiopathic peripheral facial paralysis].
Mang WL; Bonkowsky VM
HNO; 1987 Jul; 35(7):310-3. PubMed ID: 3040643
[TBL] [Abstract][Full Text] [Related]
53. Latent herpes simplex virus-1 infection in SCID mice transferred with immune CD4+T cells: a new model for latency.
Minagawa H; Yanagi Y
Arch Virol; 2000; 145(11):2259-72. PubMed ID: 11205116
[TBL] [Abstract][Full Text] [Related]
54. Early collection of saliva specimens from Bell's palsy patients: quantitative analysis of HHV-6, HSV-1, and VZV.
Turriziani O; Falasca F; Maida P; Gaeta A; De Vito C; Mancini P; De Seta D; Covelli E; Attanasio G; Antonelli G
J Med Virol; 2014 Oct; 86(10):1752-8. PubMed ID: 24619963
[TBL] [Abstract][Full Text] [Related]
55. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
Dix RD; Pereira L; Baringer JR
Infect Immun; 1981 Oct; 34(1):192-9. PubMed ID: 6271681
[TBL] [Abstract][Full Text] [Related]
56. Innate and acquired immunity to herpes simplex virus type 1.
Halford WP; Veress LA; Gebhardt BM; Carr DJ
Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
[TBL] [Abstract][Full Text] [Related]
57. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
[TBL] [Abstract][Full Text] [Related]
58. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
Ellison AR; Yang L; Voytek C; Margolis TP
Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
[TBL] [Abstract][Full Text] [Related]
59. Reactivation of type 1 herpes simplex virus and varicella zoster virus in an immunosuppressed patient with acute peripheral facial weakness.
Tsai J; Cohrs RJ; Nagel MA; Mahalingam R; Schmid DS; Choe A; Gilden D
J Neurol Sci; 2012 Feb; 313(1-2):193-5. PubMed ID: 21924743
[TBL] [Abstract][Full Text] [Related]
60. The role of B lymphocytes in experimental herpes simplex viral retinitis.
Arrunategui-Correa V; Dutt J; Foster CS
Scand J Immunol; 1994 Sep; 40(3):299-307. PubMed ID: 8091129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
